Contrary to the “cease and desist” letters issued by KV Pharmaceuticals, the FDA put out a press announcement stating that it will allow compounding pharmacies to continue to supply 17P. Read more here and here and here and here.
[April 1, 2011 – Any surprise that KV lowered the price of Makena to $690/injection? Still an exorbitant price, in my opinion, but at least KV is getting the message that they can’t charge whatever they like for Makena. There is some price competition.]
I’m counting this as a victory for all of us who are planning to receive 17P in current or future pregnancies and for all who believe in taking reasonable measures to control the costs of health care.